[Consensus document on continuous subcutaneous insulin infusion (CSII) treatment in paediatrics with type I diabetes].
This article reports on the Spanish Position Statement for the Diabetes Pediátric Group for the Spanish Pediatric Endocrinology Society (SEEP) on continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes. The practical issues about their indications, appropriate candidates, feasibility, and limits are outlined. The conclusions are based on the comprehensive review and balanced assessment of the evidence base on the international consensus and consensual answers to these questions for the participants.
Barrio Castellanos
R
R
Hospital Universitario Ramón y Cajal, Madrid, España. rbarrio.hrc@salud.madrid.org
García Cuartero
B
B
Gómez Gila
A
A
González Casado
I
I
Hermoso López
F
F
Luzuriaga Tomás
C
C
Oyarzabal Irigoyen
M
M
Rica Etxebarria
I
I
Rodríguez Rigual
M
M
Torres Lacruz
M
M
D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D055104:Infusions, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male
D007004:Hypoglycemic Agents; D007328:Insulin